Coenzyme Q10 and breast cancer:
Patients with breast cancer (n=32, aged 32-81 yrs) were treated with standard therapeutic treatment plus ANICA protocol which contained 2850 mg vitamin C, 2,500 IU vitamin E, 32.5 IU ß-carotene, 387 mcg selenium, 1.2 g gamma-linolenic acid, 3.5 g omega-3 fatty acids from fish oil, and 90 mg coenzyme Q10). All 32 patients survived the 18 months follow-up. None showed further evidence of distal metastasis. Participants reported no weight loss and a reduced use of pain killers. Remission was also reported in 6 patients. (21)
Coenzyme Q10 and chronic kidney failure:
Twenty-one individuals with chronic renal (kidney) failure either on or off dialysis were randomized to received coenzyme Q10 at 60 mg, 3 times daily (n=11) or placebo (n=10) for 4 weeks. At the end of the study period, significantly less participants were on dialysis in the coenzyme Q10 group (36.2%) than in the placebo group (90.0%).There was also a significant reduction in levels of creatinine and blood urea and a significant increase in creatinine clearance and urine output in the coenzyme Q10 group, indicating an increase in kidney function, versus the placebo group. (22)